-
2
-
-
14944385553
-
Global cancer statistics, 2002
-
Parkin DM, Bray F, Ferlay J, Pisani P,. Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55: 74-108.
-
(2005)
CA Cancer J Clin
, vol.55
, pp. 74-108
-
-
Parkin, D.M.1
Bray, F.2
Ferlay, J.3
Pisani, P.4
-
3
-
-
0036852701
-
Prostate cancer: Another aspect of the insulin-resistance syndrome?
-
Barnard RJ, Aronson WJ, Tymchuk CN, Ngo TH,. Prostate cancer: another aspect of the insulin-resistance syndrome? Obes Rev. 2002; 3: 303-308.
-
(2002)
Obes Rev
, vol.3
, pp. 303-308
-
-
Barnard, R.J.1
Aronson, W.J.2
Tymchuk, C.N.3
Ngo, T.H.4
-
4
-
-
33847740837
-
Examining the relationship between obesity and prostate cancer
-
Freedland SJ, Aronson WJ,. Examining the relationship between obesity and prostate cancer. Rev Urol. 2004; 6: 73-81.
-
(2004)
Rev Urol
, vol.6
, pp. 73-81
-
-
Freedland, S.J.1
Aronson, W.J.2
-
5
-
-
0037021505
-
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
-
Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002; 288: 2709-2716.
-
(2002)
JAMA
, vol.288
, pp. 2709-2716
-
-
Lakka, H.M.1
Laaksonen, D.E.2
Lakka, T.A.3
-
6
-
-
0347716449
-
Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey
-
Ninomiya JK, L'Italien G, Criqui MH, Whyte JL, Gamst A, Chen RS,. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation. 2004; 109: 42-46.
-
(2004)
Circulation
, vol.109
, pp. 42-46
-
-
Ninomiya, J.K.1
L'Italien, G.2
Criqui, M.H.3
Whyte, J.L.4
Gamst, A.5
Chen, R.S.6
-
7
-
-
33747883049
-
Body size and composition and prostate cancer risk: Systematic review and meta-regression analysis
-
MacInnis RJ, English DR,. Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Causes Control. 2006; 17: 989-1003.
-
(2006)
Cancer Causes Control
, vol.17
, pp. 989-1003
-
-
MacInnis, R.J.1
English, D.R.2
-
8
-
-
0242298218
-
Height, body mass index, and prostate cancer: A follow-up of 950000 Norwegian men
-
Engeland A, Tretli S, Bjorge T,. Height, body mass index, and prostate cancer: a follow-up of 950000 Norwegian men. Br J Cancer. 2003; 89: 1237-1242.
-
(2003)
Br J Cancer
, vol.89
, pp. 1237-1242
-
-
Engeland, A.1
Tretli, S.2
Bjorge, T.3
-
9
-
-
77956567266
-
Blood pressure, body size and prostate cancer risk in the Swedish Construction Workers cohort
-
Stocks T, Hergens MP, Englund A, Ye W, Stattin P,. Blood pressure, body size and prostate cancer risk in the Swedish Construction Workers cohort. Int J Cancer. 2010; 127: 1660-1668.
-
(2010)
Int J Cancer
, vol.127
, pp. 1660-1668
-
-
Stocks, T.1
Hergens, M.P.2
Englund, A.3
Ye, W.4
Stattin, P.5
-
10
-
-
79955872008
-
Body mass index, prostate cancer-specific mortality, and biochemical recurrence: A systematic review and meta-analysis
-
Cao Y, Ma J,. Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis. Cancer Prev Res (Phila). 2011; 4: 486-501.
-
(2011)
Cancer Prev Res (Phila)
, vol.4
, pp. 486-501
-
-
Cao, Y.1
Ma, J.2
-
11
-
-
0034899087
-
Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States
-
Rodriguez C, Patel AV, Calle EE, Jacobs EJ, Chao A, Thun MJ,. Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States. Cancer Epidemiol Biomarkers Prev. 2001; 10: 345-353.
-
(2001)
Cancer Epidemiol Biomarkers Prev
, vol.10
, pp. 345-353
-
-
Rodriguez, C.1
Patel, A.V.2
Calle, E.E.3
Jacobs, E.J.4
Chao, A.5
Thun, M.J.6
-
12
-
-
0037464510
-
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults
-
Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ,. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003; 348: 1625-1638.
-
(2003)
N Engl J Med
, vol.348
, pp. 1625-1638
-
-
Calle, E.E.1
Rodriguez, C.2
Walker-Thurmond, K.3
Thun, M.J.4
-
13
-
-
11844259994
-
Fasting serum glucose level and cancer risk in Korean men and women
-
Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM,. Fasting serum glucose level and cancer risk in Korean men and women. JAMA. 2005; 293: 194-202.
-
(2005)
JAMA
, vol.293
, pp. 194-202
-
-
Jee, S.H.1
Ohrr, H.2
Sull, J.W.3
Yun, J.E.4
Ji, M.5
Samet, J.M.6
-
14
-
-
74049150758
-
Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): Analysis of six prospective cohorts
-
Stocks T, Rapp K, Bjorge T, et al. Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts. PLoS Med. 2009; 6: e1000201.
-
(2009)
PLoS Med
, vol.6
-
-
Stocks, T.1
Rapp, K.2
Bjorge, T.3
-
15
-
-
40349085518
-
Obesity, metabolic syndrome, and prostate cancer
-
Hsing AW, Sakoda LC, Chua S Jr,. Obesity, metabolic syndrome, and prostate cancer. Am J Clin Nutr. 2007; 86: s843-s857.
-
(2007)
Am J Clin Nutr
, vol.86
-
-
Hsing, A.W.1
Sakoda, L.C.2
Chua, Jr.S.3
-
16
-
-
77954238561
-
The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causes
-
Grundmark B, Garmo H, Loda M, Busch C, Holmberg L, Zethelius B,. The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causes. Cancer Epidemiol Biomarkers Prev. 2010; 19: 2088-2096.
-
(2010)
Cancer Epidemiol Biomarkers Prev
, vol.19
, pp. 2088-2096
-
-
Grundmark, B.1
Garmo, H.2
Loda, M.3
Busch, C.4
Holmberg, L.5
Zethelius, B.6
-
17
-
-
68449101818
-
Components of the metabolic syndrome and risk of prostate cancer: The HUNT 2 cohort, Norway
-
Martin RM, Vatten L, Gunnell D, Romundstad P, Nilsen TI,. Components of the metabolic syndrome and risk of prostate cancer: the HUNT 2 cohort, Norway. Cancer Causes Control. 2009; 20: 1181-1192.
-
(2009)
Cancer Causes Control
, vol.20
, pp. 1181-1192
-
-
Martin, R.M.1
Vatten, L.2
Gunnell, D.3
Romundstad, P.4
Nilsen, T.I.5
-
18
-
-
79955515915
-
Prostate cancer risk in the Swedish AMORIS study: The interplay among triglycerides, total cholesterol, and glucose
-
Van Hemelrijck M, Garmo H, Holmberg L, et al. Prostate cancer risk in the Swedish AMORIS study: the interplay among triglycerides, total cholesterol, and glucose. Cancer. 2011; 117: 2086-2095.
-
(2011)
Cancer
, vol.117
, pp. 2086-2095
-
-
Van Hemelrijck, M.1
Garmo, H.2
Holmberg, L.3
-
19
-
-
33845227353
-
The metabolic syndrome is associated with reduced risk of prostate cancer
-
Tande AJ, Platz EA, Folsom AR,. The metabolic syndrome is associated with reduced risk of prostate cancer. Am J Epidemiol. 2006; 164: 1094-1102.
-
(2006)
Am J Epidemiol
, vol.164
, pp. 1094-1102
-
-
Tande, A.J.1
Platz, E.A.2
Folsom, A.R.3
-
20
-
-
79952587628
-
The effects of metabolic conditions on prostate cancer incidence over 15 years of follow-up: Results from the Olmsted County Study
-
Wallner LP, Morgenstern H, McGree ME, et al. The effects of metabolic conditions on prostate cancer incidence over 15 years of follow-up: results from the Olmsted County Study. BJU Int. 2011; 107: 929-935.
-
(2011)
BJU Int
, vol.107
, pp. 929-935
-
-
Wallner, L.P.1
Morgenstern, H.2
McGree, M.E.3
-
21
-
-
0033567222
-
Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies
-
Clarke R, Shipley M, Lewington S, et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol. 1999; 150: 341-353.
-
(1999)
Am J Epidemiol
, vol.150
, pp. 341-353
-
-
Clarke, R.1
Shipley, M.2
Lewington, S.3
-
22
-
-
0035745589
-
Random errors in the measurement of 10 cardiovascular risk factors
-
Whitlock G, Clark T, Vander Hoorn S, et al. Random errors in the measurement of 10 cardiovascular risk factors. Eur J Epidemiol. 2001; 17: 907-909.
-
(2001)
Eur J Epidemiol
, vol.17
, pp. 907-909
-
-
Whitlock, G.1
Clark, T.2
Vander Hoorn, S.3
-
23
-
-
77954475436
-
Cohort Profile: The Metabolic syndrome and Cancer project (Me-Can)
-
Stocks T, Borena W, Strohmaier S, et al. Cohort Profile: The Metabolic syndrome and Cancer project (Me-Can). Int J Epidemiol. 2010; 39: 660-667.
-
(2010)
Int J Epidemiol
, vol.39
, pp. 660-667
-
-
Stocks, T.1
Borena, W.2
Strohmaier, S.3
-
24
-
-
0037079309
-
Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies
-
Prospective Studies Collaboration.
-
Lewington S, Clarke R, Qizilbash N, Peto R, Collins R,; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002; 360: 1903-1913.
-
(2002)
Lancet
, vol.360
, pp. 1903-1913
-
-
Lewington, S.1
Clarke, R.2
Qizilbash, N.3
Peto, R.4
Collins, R.5
-
25
-
-
84870676841
-
Uptake of prostate-specific antigen testing for early prostate cancer detection in Sweden [published online ahead of print December 10, 2010]
-
Jonsson H, Holmstrom B, Duffy SW, Stattin P,. Uptake of prostate-specific antigen testing for early prostate cancer detection in Sweden [published online ahead of print December 10, 2010]. Int J Cancer.
-
Int J Cancer
-
-
Jonsson, H.1
Holmstrom, B.2
Duffy, S.W.3
Stattin, P.4
-
26
-
-
78649308573
-
Prostate cancer diagnosed after prostate-specific antigen testing of men without clinical signs of the disease: A population-based study from the National Prostate Cancer Register of Sweden
-
Steering Committee of the Swedish National Prostate Cancer Register.
-
Bratt O, Berglund A, Adolfsson J, Johansson JE, Tornblom M, Stattin P,; Steering Committee of the Swedish National Prostate Cancer Register. Prostate cancer diagnosed after prostate-specific antigen testing of men without clinical signs of the disease: a population-based study from the National Prostate Cancer Register of Sweden. Scand J Urol Nephrol. 2010; 44: 384-390.
-
(2010)
Scand J Urol Nephrol
, vol.44
, pp. 384-390
-
-
Bratt, O.1
Berglund, A.2
Adolfsson, J.3
Johansson, J.E.4
Tornblom, M.5
Stattin, P.6
-
27
-
-
38449102006
-
Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries
-
Kvale R, Auvinen A, Adami HO, et al. Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries. J Natl Cancer Inst. 2007; 99: 1881-1887.
-
(2007)
J Natl Cancer Inst
, vol.99
, pp. 1881-1887
-
-
Kvale, R.1
Auvinen, A.2
Adami, H.O.3
-
28
-
-
23844527496
-
Prostate cancer and prostate-specific antigen (PSA) screening in Austria
-
Vutuc C, Schernhammer ES, Haidinger G, Waldhor T,. Prostate cancer and prostate-specific antigen (PSA) screening in Austria. Wien Klin Wochenschr. 2005; 117: 457-461.
-
(2005)
Wien Klin Wochenschr
, vol.117
, pp. 457-461
-
-
Vutuc, C.1
Schernhammer, E.S.2
Haidinger, G.3
Waldhor, T.4
-
29
-
-
0028931857
-
Multiple significance tests: The Bonferroni method
-
Bland JM, Altman DG,. Multiple significance tests: the Bonferroni method. BMJ. 1995; 310: 170.
-
(1995)
BMJ
, vol.310
, pp. 170
-
-
Bland, J.M.1
Altman, D.G.2
-
30
-
-
33846588889
-
Regression dilution methods for meta-analysis: Assessing long-term variability in plasma fibrinogen among 27,247 adults in 15 prospective studies
-
Fibrinogen Studies Collaboration
-
Fibrinogen Studies Collaboration, Wood AM, White I, Thompson SG, Lewington S, Danesh J,. Regression dilution methods for meta-analysis: assessing long-term variability in plasma fibrinogen among 27,247 adults in 15 prospective studies. Int J Epidemiol. 2006; 35: 1570-1578.
-
(2006)
Int J Epidemiol
, vol.35
, pp. 1570-1578
-
-
Wood, A.M.1
White, I.2
Thompson, S.G.3
Lewington, S.4
Danesh, J.5
-
31
-
-
2342545425
-
Extent of regression dilution for established and novel coronary risk factors: Results from the British Regional Heart Study
-
Emberson JR, Whincup PH, Morris RW, Walker M, Lowe GD, Rumley A,. Extent of regression dilution for established and novel coronary risk factors: results from the British Regional Heart Study. Eur J Cardiovasc Prev Rehabil. 2004; 11: 125-134.
-
(2004)
Eur J Cardiovasc Prev Rehabil
, vol.11
, pp. 125-134
-
-
Emberson, J.R.1
Whincup, P.H.2
Morris, R.W.3
Walker, M.4
Lowe, G.D.5
Rumley, A.6
-
32
-
-
12444336826
-
Validity of a population-based cancer register in Sweden-an assessment of data reproducibility in the South-East region Prostate Cancer Register
-
Sandblom G, Dufmats M, Olsson M, Varenhorst E,. Validity of a population-based cancer register in Sweden-an assessment of data reproducibility in the South-East region Prostate Cancer Register. Scand J Urol Nephrol. 2003; 37: 112-119.
-
(2003)
Scand J Urol Nephrol
, vol.37
, pp. 112-119
-
-
Sandblom, G.1
Dufmats, M.2
Olsson, M.3
Varenhorst, E.4
-
33
-
-
61449257635
-
Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness
-
Larsen IK, Smastuen M, Johannesen TB, et al. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer. 2009; 45: 1218-1231.
-
(2009)
Eur J Cancer
, vol.45
, pp. 1218-1231
-
-
Larsen, I.K.1
Smastuen, M.2
Johannesen, T.B.3
-
34
-
-
33646404099
-
Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria
-
Rapp K, Schroeder J, Klenk J, et al. Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia. 2006; 49: 945-952.
-
(2006)
Diabetologia
, vol.49
, pp. 945-952
-
-
Rapp, K.1
Schroeder, J.2
Klenk, J.3
-
35
-
-
33846570585
-
Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort
-
Rodriguez C, Freedland SJ, Deka A, et al. Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev. 2007; 16: 63-69.
-
(2007)
Cancer Epidemiol Biomarkers Prev
, vol.16
, pp. 63-69
-
-
Rodriguez, C.1
Freedland, S.J.2
Deka, A.3
-
36
-
-
0041911336
-
Body mass index and risk of prostate cancer in U.S. health professionals
-
Giovannucci E, Rimm EB, Liu Y, et al. Body mass index and risk of prostate cancer in U.S. health professionals. J Natl Cancer Inst. 2003; 95: 1240-1244.
-
(2003)
J Natl Cancer Inst
, vol.95
, pp. 1240-1244
-
-
Giovannucci, E.1
Rimm, E.B.2
Liu, Y.3
-
37
-
-
55849092876
-
Body size and risk of prostate cancer in the European prospective investigation into cancer and nutrition
-
Pischon T, Boeing H, Weikert S, et al. Body size and risk of prostate cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev. 2008; 17: 3252-3261.
-
(2008)
Cancer Epidemiol Biomarkers Prev
, vol.17
, pp. 3252-3261
-
-
Pischon, T.1
Boeing, H.2
Weikert, S.3
-
38
-
-
33845328853
-
A meta-analysis of diabetes mellitus and the risk of prostate cancer
-
Kasper JS, Giovannucci E,. A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2006; 15: 2056-2062.
-
(2006)
Cancer Epidemiol Biomarkers Prev
, vol.15
, pp. 2056-2062
-
-
Kasper, J.S.1
Giovannucci, E.2
-
39
-
-
3142729250
-
Diabetes mellitus and risk of prostate cancer: A meta-analysis
-
Bonovas S, Filioussi K, Tsantes A,. Diabetes mellitus and risk of prostate cancer: a meta-analysis. Diabetologia. 2004; 47: 1071-1078.
-
(2004)
Diabetologia
, vol.47
, pp. 1071-1078
-
-
Bonovas, S.1
Filioussi, K.2
Tsantes, A.3
-
40
-
-
11844252683
-
Diabetes and risk of prostate cancer in a prospective cohort of US men
-
Rodriguez C, Patel AV, Mondul AM, Jacobs EJ, Thun MJ, Calle EE,. Diabetes and risk of prostate cancer in a prospective cohort of US men. Am J Epidemiol. 2005; 161: 147-152.
-
(2005)
Am J Epidemiol
, vol.161
, pp. 147-152
-
-
Rodriguez, C.1
Patel, A.V.2
Mondul, A.M.3
Jacobs, E.J.4
Thun, M.J.5
Calle, E.E.6
-
41
-
-
55849153130
-
Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
-
Prostate, Lung, Colorectal, and Ovarian Trial Project Team.
-
Leitzmann MF, Ahn J, Albanes D, et al. Prostate, Lung, Colorectal, and Ovarian Trial Project Team. Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Causes Control. 2008; 19: 1267-1276.
-
(2008)
Cancer Causes Control
, vol.19
, pp. 1267-1276
-
-
Leitzmann, M.F.1
Ahn, J.2
Albanes, D.3
-
42
-
-
34247519153
-
Insulin resistance is inversely related to prostate cancer: A prospective study in Northern Sweden
-
Stocks T, Lukanova A, Rinaldi S, et al. Insulin resistance is inversely related to prostate cancer: a prospective study in Northern Sweden. Int J Cancer. 2007; 120: 2678-2686.
-
(2007)
Int J Cancer
, vol.120
, pp. 2678-2686
-
-
Stocks, T.1
Lukanova, A.2
Rinaldi, S.3
-
43
-
-
80053256686
-
Body mass index in early and middle-late adulthood and risk of localised, advanced and fatal prostate cancer: A population-based prospective study
-
Discacciati A, Orsini N, Andersson SO, Andren O, Johansson JE, Wolk A,. Body mass index in early and middle-late adulthood and risk of localised, advanced and fatal prostate cancer: a population-based prospective study. Br J Cancer. 2011; 105: 1061-1068.
-
(2011)
Br J Cancer
, vol.105
, pp. 1061-1068
-
-
Discacciati, A.1
Orsini, N.2
Andersson, S.O.3
Andren, O.4
Johansson, J.E.5
Wolk, A.6
-
44
-
-
34250745251
-
Obesity and prostate cancer: Epidemiology and clinical implications
-
Buschemeyer WC 3rd, Freedland SJ,. Obesity and prostate cancer: epidemiology and clinical implications. Eur Urol. 2007; 52: 331-343.
-
(2007)
Eur Urol
, vol.52
, pp. 331-343
-
-
Buschemeyer III, W.C.1
Freedland, S.J.2
-
45
-
-
34247869042
-
The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas
-
Giovannucci E, Michaud D,. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology. 2007; 132: 2208-2225.
-
(2007)
Gastroenterology
, vol.132
, pp. 2208-2225
-
-
Giovannucci, E.1
Michaud, D.2
-
46
-
-
79951723982
-
Modifiable risk factors for prostate cancer mortality in London: Forty years of follow-up in the Whitehall study
-
Batty GD, Kivimaki M, Clarke R, Davey Smith G, Shipley MJ,. Modifiable risk factors for prostate cancer mortality in London: forty years of follow-up in the Whitehall study. Cancer Causes Control. 2011; 22: 311-318.
-
(2011)
Cancer Causes Control
, vol.22
, pp. 311-318
-
-
Batty, G.D.1
Kivimaki, M.2
Clarke, R.3
Davey Smith, G.4
Shipley, M.J.5
-
47
-
-
0242361185
-
Blood pressure and site-specific cancer mortality: Evidence from the original Whitehall study
-
Whitehall Study.
-
Batty GD, Shipley MJ, Marmot MG, Davey Smith G,; Whitehall Study. Blood pressure and site-specific cancer mortality: evidence from the original Whitehall study. Br J Cancer. 2003; 89: 1243-1247.
-
(2003)
Br J Cancer
, vol.89
, pp. 1243-1247
-
-
Batty, G.D.1
Shipley, M.J.2
Marmot, M.G.3
Davey Smith, G.4
-
48
-
-
40449130549
-
The impact of modifiable risk factors on mortality from prostate cancer in populations of the Asia-Pacific region
-
Asia Pacific Cohort Studies Collaboration.
-
Huxley R,; Asia Pacific Cohort Studies Collaboration. The impact of modifiable risk factors on mortality from prostate cancer in populations of the Asia-Pacific region. Asian Pac J Cancer Prev. 2007; 8: 199-205.
-
(2007)
Asian Pac J Cancer Prev
, vol.8
, pp. 199-205
-
-
Huxley, R.1
-
49
-
-
66949112574
-
Metabolic syndrome and risk of cancer mortality in men
-
Jaggers JR, Sui X, Hooker SP, et al. Metabolic syndrome and risk of cancer mortality in men. Eur J Cancer. 2009; 45: 1831-1838.
-
(2009)
Eur J Cancer
, vol.45
, pp. 1831-1838
-
-
Jaggers, J.R.1
Sui, X.2
Hooker, S.P.3
-
50
-
-
33749471265
-
Metabolic syndrome predicts prostate cancer in a cohort of middle-aged Norwegian men followed for 27 years
-
Lund Haheim L, Wisloff TF, Holme I, Nafstad P,. Metabolic syndrome predicts prostate cancer in a cohort of middle-aged Norwegian men followed for 27 years. Am J Epidemiol. 2006; 164: 769-774.
-
(2006)
Am J Epidemiol
, vol.164
, pp. 769-774
-
-
Lund Haheim, L.1
Wisloff, T.F.2
Holme, I.3
Nafstad, P.4
-
51
-
-
4944223630
-
Metabolic syndrome and the risk of prostate cancer in Finnish men: A population-based study
-
Laukkanen JA, Laaksonen DE, Niskanen L, Pukkala E, Hakkarainen A, Salonen JT,. Metabolic syndrome and the risk of prostate cancer in Finnish men: a population-based study. Cancer Epidemiol Biomarkers Prev. 2004; 13: 1646-1650.
-
(2004)
Cancer Epidemiol Biomarkers Prev
, vol.13
, pp. 1646-1650
-
-
Laukkanen, J.A.1
Laaksonen, D.E.2
Niskanen, L.3
Pukkala, E.4
Hakkarainen, A.5
Salonen, J.T.6
|